Swanson DP - Search Results

1

Procedure guideline for imaging with radiopharmaceuticals: 1.0. Society of Nuclear Medicine.

Callahan RJ, Chilton HM, Goodwin DA, Hnatowich DJ, Ponto JA, Swanson DP, Royal HJ. Callahan RJ, et al. Among authors: swanson dp. J Nucl Med. 1996 Dec;37(12):2092-4. J Nucl Med. 1996. PMID: 8970541 Free article. No abstract available.

2

Procedure guideline for the use of radiopharmaceuticals 4.0.

Callahan RJ, Chilton HM, Ponto JA, Swanson DP, Royal HD, Bruce AD. Callahan RJ, et al. Among authors: swanson dp. J Nucl Med Technol. 2007 Dec;35(4):272-5. doi: 10.2967/jnmt.107.044156. Epub 2007 Nov 15. J Nucl Med Technol. 2007. PMID: 18006598 Free article. No abstract available.

3

The future of USP monographs for PET drugs.

Schwarz S, Norenberg J, Berridge M, Dragotakes S, Hung J, Link J, Mason NS, Mattmuller S, Nickel RA, Packard A, Paolino J, Petry N, Ponto J, Quinton TM, Seifert KL, Swanson D, Weiner RE, Zigler S. Schwarz S, et al. J Nucl Med. 2013 Mar;54(3):472-5. doi: 10.2967/jnumed.112.115089. Epub 2012 Dec 21. J Nucl Med. 2013. PMID: 23264689 Free article. No abstract available.

4

Explanations and unresolved issues pertaining to the development of the Nuclear Pharmacy Compounding Guidelines.

Hung JC, Augustine SC, Cheng KT, Green RL, Hopkins WM, Laven DL, Nelson BR, Petry NA, Ponto JA, Quinton TM, Swanson DP. Hung JC, et al. Among authors: swanson dp. J Am Pharm Assoc (Wash). 2002 Sep-Oct;42(5):789-98. doi: 10.1331/108658002764653568. J Am Pharm Assoc (Wash). 2002. PMID: 12269713

5

Diagnostic interventions in nuclear medicine.

Thrall JH, Swanson DP. Thrall JH, et al. Among authors: swanson dp. Curr Probl Diagn Radiol. 1989 Jan-Feb;18(1):1-37. doi: 10.1016/0363-0188(89)90003-0. Curr Probl Diagn Radiol. 1989. PMID: 2646073 Review.

6

Development of nonionic gamma-emitting radiopharmaceuticals for myocardial imaging.

Thrall JH, Swanson DP, Wieland DM. Thrall JH, et al. Among authors: swanson dp. J Nucl Med. 1978 Aug;19(8):969-71. J Nucl Med. 1978. PMID: 682032 Free article. No abstract available.

7

Altered biodistribution of 6 beta-[131I]-iodomethyl-19-norcholesterol (NP-59): radiopharmaceutical contamination or patient idiosyncracy?

Swanson DP, Wirth NE, Gross MD. Swanson DP, et al. J Nucl Med. 1979 Jul;20(7):805-6. J Nucl Med. 1979. PMID: 541724 Free article. No abstract available.

8

Myocardial imaging in man with I-123 meta-iodobenzylguanidine.

Kline RC, Swanson DP, Wieland DM, Thrall JH, Gross MD, Pitt B, Beierwaltes WH. Kline RC, et al. Among authors: swanson dp. J Nucl Med. 1981 Feb;22(2):129-32. J Nucl Med. 1981. PMID: 7463156 Free article.

9

Current good manufacturing practices for PET drug products in the United States.

Swanson D, Graham M, Heinonen TM, Libby P, Mills GQ. Swanson D, et al. J Nucl Med. 2009 Aug;50(8):26N-8N. J Nucl Med. 2009. PMID: 19652213 Free article. No abstract available.

10

Adrenal imaging with iodomethyl-norcholesterol (I-131) in primary aldosteronism.

Freitas JE, Grekin RJ, Thrall JH, Gross MD, Swanson DP, Beierwaltes WH. Freitas JE, et al. Among authors: swanson dp. J Nucl Med. 1979 Jan;20(1):7-10. J Nucl Med. 1979. PMID: 430181 Free article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

98 results

Search Page

Filters